EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis
FRA:ESF0 - Deutsche Boerse Ag - FR0014000MR3 - Common Stock - Currency: EUR
Overall ESF0 gets a fundamental rating of 6 out of 10. We evaluated ESF0 against 17 industry peers in the Life Sciences Tools & Services industry. ESF0 scores excellent on profitability, but there are some minor concerns on its financial health. ESF0 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ESF0 had positive earnings in the past year.
ESF0 had a positive operating cash flow in the past year.
Each year in the past 5 years ESF0 has been profitable.
Each year in the past 5 years ESF0 had a positive operating cash flow.
1.2 Ratios
ESF0's Return On Assets of 3.24% is fine compared to the rest of the industry. ESF0 outperforms 70.59% of its industry peers.
ESF0 has a better Return On Equity (6.61%) than 70.59% of its industry peers.
The Return On Invested Capital of ESF0 (9.18%) is better than 76.47% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ESF0 is in line with the industry average of 6.91%.
The last Return On Invested Capital (9.18%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.24% | ||
| ROE | 6.61% | ||
| ROIC | 9.18% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
ESF0's Profit Margin of 5.08% is in line compared to the rest of the industry. ESF0 outperforms 52.94% of its industry peers.
In the last couple of years the Profit Margin of ESF0 has grown nicely.
The Operating Margin of ESF0 (14.97%) is better than 64.71% of its industry peers.
In the last couple of years the Operating Margin of ESF0 has grown nicely.
ESF0 has a Gross Margin of 22.33%. This is amonst the worse of the industry: ESF0 underperforms 82.35% of its industry peers.
ESF0's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.97% | ||
| PM (TTM) | 5.08% | ||
| GM | 22.33% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ESF0 is still creating some value.
Compared to 1 year ago, ESF0 has less shares outstanding
ESF0 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ESF0 has an improved debt to assets ratio.
2.2 Solvency
ESF0 has an Altman-Z score of 2.74. This is not the best score and indicates that ESF0 is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ESF0 (2.74) is comparable to the rest of the industry.
The Debt to FCF ratio of ESF0 is 4.57, which is a neutral value as it means it would take ESF0, 4.57 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ESF0 (4.57) is better than 64.71% of its industry peers.
ESF0 has a Debt/Equity ratio of 0.59. This is a neutral value indicating ESF0 is somewhat dependend on debt financing.
ESF0 has a Debt to Equity ratio (0.59) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 4.57 | ||
| Altman-Z | 2.74 |
ROIC/WACC1.2
WACC7.66%
2.3 Liquidity
A Current Ratio of 1.16 indicates that ESF0 should not have too much problems paying its short term obligations.
ESF0 has a Current ratio of 1.16. This is amonst the worse of the industry: ESF0 underperforms 82.35% of its industry peers.
A Quick Ratio of 1.09 indicates that ESF0 should not have too much problems paying its short term obligations.
The Quick ratio of ESF0 (1.09) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.63% over the past year.
Measured over the past years, ESF0 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
The Revenue has been growing slightly by 6.70% in the past year.
ESF0 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.78% yearly.
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%13.46%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%
3.2 Future
The Earnings Per Share is expected to grow by 13.47% on average over the next years. This is quite good.
Based on estimates for the next years, ESF0 will show a small growth in Revenue. The Revenue will grow by 6.47% on average per year.
EPS Next Y15.29%
EPS Next 2Y14.58%
EPS Next 3Y14%
EPS Next 5Y13.47%
Revenue Next Year6.31%
Revenue Next 2Y6.36%
Revenue Next 3Y6.54%
Revenue Next 5Y6.47%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 33.63, which means the current valuation is very expensive for ESF0.
Compared to the rest of the industry, the Price/Earnings ratio of ESF0 is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.35, ESF0 is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 17.00, the valuation of ESF0 can be described as rather expensive.
76.47% of the companies in the same industry are more expensive than ESF0, based on the Price/Forward Earnings ratio.
ESF0 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.63 | ||
| Fwd PE | 17 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaply inside the industry as 88.24% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ESF0 is valued cheaply inside the industry as 94.12% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.95 | ||
| EV/EBITDA | 8.09 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ESF0 may justify a higher PE ratio.
A more expensive valuation may be justified as ESF0's earnings are expected to grow with 14.00% in the coming years.
PEG (NY)2.2
PEG (5Y)1.83
EPS Next 2Y14.58%
EPS Next 3Y14%
5. Dividend
5.1 Amount
ESF0 has a Yearly Dividend Yield of 1.01%. Purely for dividend investing, there may be better candidates out there.
ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.74. ESF0 pays more dividend than 88.24% of the companies in the same industry.
With a Dividend Yield of 1.01, ESF0 pays less dividend than the S&P500 average, which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.01% |
5.2 History
On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
27.77% of the earnings are spent on dividend by ESF0. This is a low number and sustainable payout ratio.
ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.77%
EPS Next 2Y14.58%
EPS Next 3Y14%
FRA:ESF0 (6/19/2025, 7:00:00 PM)
60.54
-0.48 (-0.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners34.16%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.03B
Analysts68.89
Price Target61.93 (2.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.01% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP27.77%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.76%
PT rev (3m)0.51%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.63 | ||
| Fwd PE | 17 | ||
| P/S | 1.59 | ||
| P/FCF | 13.95 | ||
| P/OCF | 8.36 | ||
| P/B | 2.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.09 |
EPS(TTM)1.8
EY2.97%
EPS(NY)3.56
Fwd EY5.88%
FCF(TTM)4.34
FCFY7.17%
OCF(TTM)7.24
OCFY11.96%
SpS38.16
BVpS29.31
TBVpS-1.59
PEG (NY)2.2
PEG (5Y)1.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.24% | ||
| ROE | 6.61% | ||
| ROCE | 11.86% | ||
| ROIC | 9.18% | ||
| ROICexc | 9.87% | ||
| ROICexgc | 31.79% | ||
| OM | 14.97% | ||
| PM (TTM) | 5.08% | ||
| GM | 22.33% | ||
| FCFM | 11.37% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexcg growth 3Y-18.17%
ROICexcg growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score8
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 4.57 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 76.4% | ||
| Cap/Sales | 7.6% | ||
| Interest Coverage | 9.11 | ||
| Cash Conversion | 76.13% | ||
| Profit Quality | 224% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 2.74 |
F-Score8
WACC7.66%
ROIC/WACC1.2
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%13.46%
EPS Next Y15.29%
EPS Next 2Y14.58%
EPS Next 3Y14%
EPS Next 5Y13.47%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%
Revenue Next Year6.31%
Revenue Next 2Y6.36%
Revenue Next 3Y6.54%
Revenue Next 5Y6.47%
EBIT growth 1Y23.67%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year87.7%
EBIT Next 3Y30.85%
EBIT Next 5Y22.29%
FCF growth 1Y68.95%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y29.56%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%